How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

9,398 results for

Cholesterol Education Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Nutritional Therapy and Education With Multimedia Application in Patients With Type 2 Diabetes

and Education With a Multimedia Application in the Metabolic Control of Patients With Type 2 Diabetes. Randomized Clinical Trial Study Start Date : March 2013 Actual Primary Completion Date : December 2014 Actual Study Completion Date : December 2015 Resource links provided by the National Library of Medicine related topics: related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Nutritional therapy and education Nutritional therapy guidance according to sex, age, weight (...) Nutritional Therapy and Education With Multimedia Application in Patients With Type 2 Diabetes Nutritional Therapy and Education With Multimedia Application in Patients With Type 2 Diabetes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2015 Clinical Trials

42. Nutrition Education for Cardiovascular Disease Prevention in Spinal Cord Injury

Description: The prevalence of SCI is significant. Obesity, diabetes, and CVD are more prevalent in the SCI population. Many individuals with SCI are unable or have a limited capacity to exercise. This reality makes good nutrition even more urgent. This study will be the first to test whether additional nutrition education can improve nutrition behavior and knowledge, diet quality, adiposity, and metabolic CVD risk factors in individuals with SCI and to determine the best setting to deliver nutrition (...) nutrition education session approximately 3 months after receipt of the Eat Smart, Live Better curriculum. In order to help us assess the effectiveness of the nutrition education program, we will assess nutrition behavior and knowledge at this time as well. Community participants in the treatment group will attend the sessions at Carolinas Rehabilitation (CR). The control participants from the community will come to CR for the one standard nutrition lecture. Caregivers and spouses of all

2015 Clinical Trials

43. The Effectiveness of a Home-based Interactive E-health Educational Intervention for Middle-aged Cardiovascular Disease Adults in Improving Total Exercise, Adherence Rate, Exercise Efficacy and Outcomes

Educational Intervention for Middle-aged Cardiovascular Disease Adults in Improving Total Exercise, Adherence Rate, Exercise Efficacy and Outcomes Study Start Date : June 2013 Actual Primary Completion Date : July 2015 Actual Study Completion Date : July 2015 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: e-health educational intervention (eHEI) Participants in the intervention group received usual care (...) and additional individualized educational intervention administered by a trained nurse who was experienced in cardiac nursing. The exercise prescription had been set as walking exercise for 30 minutes per day for 5 days per week. The exercise dosage might be modified with physician's order to suit the individual's physical condition and agreed goals if necessary. The 30- minutes educational intervention was conducted in a private room of the clinic. The content covered general information related to coronary

2015 Clinical Trials

44. Online WIC Nutrition Education to Promote Farmers' Market Fruit and Vegetable Purchases and Consumption

education lesson to promote fruit and vegetable (FV) consumption among women enrolled in the Special Supplemental Nutrition Program for Women, Infants and Children (WIC). Designed to leverage vouchers provided to WIC participants for FV purchases through the Farmers' Market Nutrition Program (FMNP) and monthly cash value vouchers (CVVs) redeemable at farmers' markets, the lesson is conceptually grounded in formative research on knowledge, attitudes and skills influencing farmers' market FV purchases (...) Education to Promote Farmers' Market Fruit and Vegetable Purchases and Consumption Study Start Date : July 2014 Estimated Primary Completion Date : June 2016 Estimated Study Completion Date : June 2016 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: WIC Fresh Start Program Participants in this arm receive the Fresh Start program. Behavioral: WIC Fresh Start Program The intervention is an online lesson

2015 Clinical Trials

45. CPR Education Via a Mobile Application Compared to VSI Kit

, studies have suggested that providing CPR training to family members of hospitalized cardiac patients may serve as a useful approach to address an environment in which bystander CPR is frequently not provided. Utilizing an existing in-hospital program to train adult family members, the investigators will assess the skills of those who learn CPR through two different educational methods: a mobile app and video self-instruction (VSI). Condition or disease Intervention/treatment Phase Cardiovascular Risk (...) : VSI Kit Education: CPR Training using the CPR Anytime VSI Kit Individuals will learn chest-compression only CPR (no rescue breaths) using the American Heart Association's Family and Friends CPR Anytime Kit. Subjects will undergo training in-hospital and will be encouraged to take the kit home to share with their family members and friends. Other: Education: CPR Training using the CPR Anytime VSI Kit Subjects will be trained using the American Heart Association's Family and Friends CPR Anytime Kit

2015 Clinical Trials

46. Development of an electronic health message system to support recovery after stroke: Inspiring Virtual Enabled Resources following Vascular Events (iVERVE) Full Text available with Trip Pro

Development of an electronic health message system to support recovery after stroke: Inspiring Virtual Enabled Resources following Vascular Events (iVERVE) Worldwide, stroke is a leading cause of disease burden. Many survivors have unmet needs after discharge from hospital. Electronic communication technology to support post-discharge care has not been used for patients with stroke. In this paper, we describe the development of a novel electronic messaging system designed for survivors (...) for the goal-setting menu, we drafted relevant messages to support and educate patients. These messages were then independently reviewed by multiple topic experts. Concurrently, we established an online database to capture participant characteristics and then integrated this database with a purpose-built messaging system. We conducted alpha testing of the approach using the first 60 messages.The initial goal-setting menu comprised 26 subcategories. Following expert review, another 8 goal subcategories were

2018 Patient preference and adherence

47. Efficacy and Safety of Unripe Bokbunja Extract on Improvement of Blood Cholesterol

Secondary Outcome Measures : Changes of Lipid profile(total cholesterol, LDL-cholesterol, triglyceride, HDL-cholesterol, free fatty acid, Apolipoprotein A1, Apolipoprotein B, Lipoprotein a, hs-CRP) [ Time Frame: 12 weeks ] Changes of lipid profile(total cholesterol, LDL-cholesterol, triglyceride, HDL-cholesterol, free fatty acid, Apolipoprotein A1, Apolipoprotein B, Lipoprotein a, hs-CRP) were assessed before and after the intervention Changes of Arteriosclerosis index(total cholesterol/HDL-cholesterol (...) -week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Unripe Bokbunja Extract on Improvement of Blood Cholesterol Actual Study Start Date : December 2016 Actual Primary Completion Date : May 2017 Actual Study Completion Date : February 2018 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: unripe Bokbunja Extract tablet(1 tablet/d, 600 mg/d) for 12 weeks

2018 Clinical Trials

48. Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI

to Primary Outcome Measures : Percent change in direct LDL cholesterol [ Time Frame: 6 weeks ] Secondary Outcome Measures : Percent change in Apo B [ Time Frame: 6 weeks ] Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts (...) Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2018 Clinical Trials

49. The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics

Assignment Intervention Model Description: case control study Masking: Double (Participant, Investigator) Masking Description: two groups of participants and investigator Primary Purpose: Prevention Official Title: The Disparity of Hawthorn Effects to Triglyceride/High-density Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics Actual Study Start Date : January 1, 2013 Actual Primary Completion Date : December 31, 2013 Actual Study Completion Date : July 31, 2014 Resource links provided (...) The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2018 Clinical Trials

50. Dietary Cholesterol and Adipose Tissue Inflammation

transcriptome analyses. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 130 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Basic Science Official Title: Cholesterol Mobilization and Adipocyte Function in Humans Estimated Study Start Date : April 2019 Estimated Primary Completion Date : December 2019 Estimated Study Completion Date : December 2019 Resource links (...) containing either no added cholesterol or 1g/day added cholesterol were eaten for three weeks prior to surgery. Tissue samples will be taken from non-obese participants undergoing elective abdominal surgery to be used to measure inflammatory gene expression. Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about

2018 Clinical Trials

51. Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol

, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C) Actual Study Start Date : December 21, 2017 Estimated Primary Completion Date : October 2019 Estimated Study Completion Date : December 2019 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment (...) Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum

2018 Clinical Trials

52. Inclisiran for Subjects With ACSVD or ACSVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol

, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) or ACSVD Risk-Equivalents and Elevated Low-Density Lipoprotein Cholesterol (LDL-C) Actual Study Start Date : November 1, 2017 Estimated Primary Completion Date : October 2019 Estimated Study Completion Date : December 2019 Resource links provided by the National Library of Medicine related topics: Arms and Interventions (...) Inclisiran for Subjects With ACSVD or ACSVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol Inclisiran for Subjects With ACSVD or ACSVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2018 Clinical Trials

53. Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients

Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients (EVOLVD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details

2018 Clinical Trials

54. Viscosity of Fibre Predicts Cholesterol-lowering in Healthy Individuals

(Clinical Trial) Actual Enrollment : 23 participants Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double (Participant, Investigator) Primary Purpose: Treatment Official Title: Viscosity Rather Than Quality of Dietary Fibre Predicts Cholesterol-lowering Effect in Healthy Individuals Actual Study Start Date : January 1992 Actual Primary Completion Date : January 1994 Actual Study Completion Date : July 2010 Resource links provided by the National Library of Medicine related (...) Viscosity of Fibre Predicts Cholesterol-lowering in Healthy Individuals Viscosity of Fibre Predicts Cholesterol-lowering in Healthy Individuals - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Viscosity

2018 Clinical Trials

55. Effect of a Treatment With a Nutraceutical Combination on Sub-optimal LDL Cholesterol Levels

) Primary Purpose: Treatment Official Title: A Randomized, Double-blinded, Placebo-controlled, Clinical Study of the Effects of a Nutraceutical Combination on LDL Cholesterol Levels in Subjects With Sub-optimal Blood Cholesterol Levels Actual Study Start Date : October 12, 2017 Actual Primary Completion Date : August 29, 2018 Actual Study Completion Date : August 29, 2018 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment (...) Effect of a Treatment With a Nutraceutical Combination on Sub-optimal LDL Cholesterol Levels Effect of a Treatment With a Nutraceutical Combination on Sub-optimal LDL Cholesterol Levels - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2018 Clinical Trials

56. Effect of Dietary Cholesterol on Plasma Lipids

Completion Date : November 20, 2018 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Dietary Effect of Cholesterol - Egg Phase In a randomized, 9-week crossover trial, we will test the effects of dietary cholesterol in individuals without baseline cholesterol intake through two 4-week dietary intervention periods, using baked goods containing egg yolks or egg-free baked goods. During the egg phase (...) of Dietary Cholesterol on Plasma Lipids [ Time Frame: 9 weeks total ] Examining the change of plasma lipids after consuming dietary cholesterol daily for one of two 4 week intervention periods with a 1 week washout period. Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may

2018 Clinical Trials

57. Effects of Soy Protein on Cholesterol Levels in Children Affected With Familial Hypercholesterolemia

. This was done to confirm adherence to the routine dietary treatment. Furthermore, all patients had been screened for metabolic diseases other than FH as part of their initial routine assessment in our specialised centre. Subjects in both groups had been instructed to achieve specific daily maximum intakes in total fat (≤ 30% of total energy intake), saturated fatty acids (≤10% of total fat intake) and cholesterol (≤ 300 mg). Furthermore the participating families had been trained to replace as many visible (...) by the National Library of Medicine related topics: related topics: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Fat modified diet Subjects in this arm had been instructed to achieve specific daily maximum intakes in total fat (≤ 30% of total energy intake), saturated fatty acids (≤10% of total fat intake) and cholesterol (≤ 300 mg). Furthermore the participating families had been trained to replace as many visible fat sources as possible with rapeseed oil due to its favorable

2018 Clinical Trials

58. Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)

: Double (Participant, Care Provider) Primary Purpose: Treatment Official Title: Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C). Actual Study Start Date : November 28, 2017 Estimated Primary Completion Date : September 2019 Estimated Study Completion Date : September 2019 Resource links (...) Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH) Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms

2018 Clinical Trials

59. Safety and Efficacy of Propionate for Reduction of LDL Cholesterol

: Charite University, Berlin, Germany Information provided by (Responsible Party): Arash Haghikia, Charite University, Berlin, Germany Study Details Study Description Go to Brief Summary: The objective of the trial is to evaluate a potential impact of food supplements with the short chain fatty acid propionate on blood LDL cholesterol level. Condition or disease Intervention/treatment Phase Hypercholesterolemia Drug: Atorvastatin 10mg Dietary Supplement: Calcium-Propionate 500mg Other: Placebo Phase 2 (...) -blind Trial Actual Study Start Date : November 21, 2017 Estimated Primary Completion Date : November 30, 2019 Estimated Study Completion Date : November 30, 2020 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Arm 1 31 patients will be treated with 500mg Calcium-Propionate capsules (twice a day) in addition to their basic cholesterol lowering therapy with 10mg Atorvastatin (once per day) for 8

2018 Clinical Trials

60. The Dual Impact of Homocysteine and Cholesterol on Cognitive Functions

: June 1, 2018 Actual Study Completion Date : August 1, 2018 Resource links provided by the National Library of Medicine related topics: resources: Groups and Cohorts Go to Group/Cohort Intervention/treatment Apparently normal participants Participants are not complaining from any cognitive decline are subjected to cognitive and cholesterol and homocysteine levels assessment. Diagnostic Test: Blood sampling for total cholesterol and homocysteine and cognitive assessment by psychometric tests. all (...) for additional information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Keywords provided by MWAmeen, Assiut University: Cholesterol Dementia Homocysteine Cognitive dysfunctions Additional relevant MeSH terms: Layout table for MeSH terms Hypercholesterolemia Cognitive Dysfunction Hyperhomocysteinemia Hyperlipidemias Dyslipidemias Lipid Metabolism Disorders Metabolic Diseases Cognition Disorders Neurocognitive Disorders Mental Disorders Amino Acid Metabolism

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>